The Scientific Advisory Board is composed of leading epilepsy researchers from both academia and industry with expertise spanning a broad range of disciplines. The SAB members assess grant and investment opportunities and also share their expertise to guide researchers in most effectively advancing new therapy projects. The SAB also provides strategic direction to guide the programs of the organization.

• Jacqueline French, M.D.: Vice President for Clinical Research; Chair, Scientific Advisory Board; Professor of Neurology, NYU Comprehensive Epilepsy Center, New York University; Director Epilepsy Study Consortium
• Orrin Devinsky, M.D.Co-Founder; Vice President for Translational Programs; Professor of Neurology, Neurosurgery and Psychiatry and Director, NYU Comprehensive Epilepsy Center, New York University
•  Ray Dingledine, Ph.D.
  Chair, Department of Pharmacology, Emory University
• Robert Fisher, M.D., Ph.D.
  Professor of Neurology and Director, Stanford Comprehensive Epilepsy Center, Stanford University
• Elizabeth Garofalo, M.D.
  President, Technical Center; Michigan Technology and Research Institute
• Frances Jensen, M.D.
  Senior Associate in Medicine, Department of Neurology, Children's Hospital, Boston; Associate Professor of Neurology Harvard Medical School
• Brian Litt, M.D.
  Assistant Professor of Neurology, Assistant Professor of Bioengineering, University of Pennsylvania
• Daniel H. Lowenstein, M.D.
  Professor of Neurology and Director, UCSF Epilepsy Program, University of California, San Francisco
• Roger J. Porter, MD
  Consultant; Adjunct Professor of Neurology, University of Pennsylvania, Philadelphia; Adjunct Professor of Pharmacology, USUHS, Bethesda
• Steven C. Schachter, M.D.
  Professor of Neurology and Director of Research, Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center
• Joyce A. Cramer (ex officio), President, Epilepsy Therapy Project and Associate Research Scientist, Yale University School of Medicine

Continue to: Business Advisory Board